anonymous
Guest
anonymous
Guest
Anyone seriously think the cuts are seriously done? Restasis is basically on life support and the glaucoma portfolio really doesnt show much annual growth.
They've been saying for years that the dry eye franchise was the future of eye care now thats been blown up like an Irish car bomb.
Seems to me that lumigan, combigan and alphagan could easily be handled by an inside sales team and samples could be shipped. Just some thoughts to ponder as I look at this gigantic territory with 80% glaucoma weighting with nothing really new to say.....
They've been saying for years that the dry eye franchise was the future of eye care now thats been blown up like an Irish car bomb.
Seems to me that lumigan, combigan and alphagan could easily be handled by an inside sales team and samples could be shipped. Just some thoughts to ponder as I look at this gigantic territory with 80% glaucoma weighting with nothing really new to say.....